Home
/

What is a Ferritin-to-Albumin Ratio Blood Test?

REVIEWED BY
Bill Maish, MD
Clinical Content Consultant
Published
May 30, 2026
Last updated
May 30, 2026
Quick answer:

The Ferritin-to-Albumin Ratio (FAR) combines ferritin (rises with inflammation) and albumin (falls during stress) to capture the balance between inflammatory activation and protein synthetic reserve. High FAR is associated with infection, autoimmune disease, metabolic syndrome, and worse outcomes in sepsis and cardiovascular disease, while low FAR may help support assessment of adequate nutrition or iron deficiency. FAR integrates iron metabolism, liver function, and inflammatory stress into one marker.

Read more →
Table of contents

FAR: ferritin and albumin as opposing acute-phase proteins

The Ferritin-to-Albumin Ratio (FAR) is a composite blood marker that compares two familiar proteins. Ferritin is the body's iron storage protein, mainly kept inside liver and immune cells and released into the bloodstream in small amounts (ferritin; hepatocytes; macrophages). Albumin is the principal protein made by the liver that circulates in plasma and carries many substances (albumin; hepatic synthesis; plasma protein). FAR is derived by relating the measured ferritin to albumin in a blood sample to capture their balance.

FAR reflects the interplay between iron handling and inflammation on one side, and the body's protein-making capacity and reserves on the other. Ferritin tends to rise during inflammation or cellular stress (acute-phase reactant), while albumin often decreases with systemic stress (negative acute-phase reactant) and helps maintain fluid balance and molecular transport. By bringing these opposing signals together, FAR offers an integrated snapshot of systemic inflammatory activity, liver synthetic function, and overall physiological stress, grounded in iron metabolism and protein homeostasis.

Why one ratio bundles iron, inflammation, and nutrition

The ferritin-to-albumin ratio (FAR) links iron storage with inflammation and the body's protein-making state. Ferritin rises with immune activation as well as iron load; albumin falls with inflammation and malnutrition. Together, FAR integrates iron metabolism, liver function, nutrition, and vascular fluid balance. There is no universal reference range because formulas differ, but in healthy adults it sits low; within reference ranges is toward the low end if ferritin is not deficient.

Low and high FAR patterns

A low ratio can reflect strong albumin with modest ferritin—consistent with low inflammatory tone. When ferritin is truly low, it signals iron deficiency that limits oxygen delivery and cellular energy. Tiredness, lower exercise tolerance, hair shedding, and restless legs may appear. Menstruating women are most affected. Pregnancy lowers albumin via hemodilution, so FAR needs trimester context.

A high ratio usually combines ferritin elevation and/or albumin depression—an inflammatory, catabolic signal seen with infection, autoimmune activity, liver or kidney disease, metabolic syndrome, or cancer. It aligns with edema and poor wound healing (low albumin), malaise or fevers (inflammation), and anemia of inflammation despite adequate iron. Higher FAR has been linked to worse outcomes in sepsis, cardiovascular and renal disease, and several cancers.

Being in range suggests adequate iron stores, low inflammatory burden, and intact liver protein synthesis, supporting steady oxygen delivery and immune balance. In health, FAR often lies toward the lower end when albumin is robust and ferritin is sufficient but not elevated.

What can shift ferritin or albumin separately

FAR depends on assay and population; reference intervals vary. Acute illness, surgery, and trauma can transiently raise it. Hydration and methods affect albumin. Recent iron therapy, transfusion, estrogens, and glucocorticoids shift components; pairing with CRP and blood counts clarifies cause. Elevated ratios also appear in chronic kidney disease, cirrhosis, nephrotic loss, heart failure, older age, and late pregnancy.

Interpret FAR with a complete blood count, transferrin saturation, CRP, and liver–kidney tests to gauge how immune, hepatic, renal, and hematologic systems are coping. Persistently high ratios suggest inflammatory stress and protein loss tied to vascular disease, frailty, complications, and slower recovery. The ferritin-to-albumin ratio (FAR) compares ferritin, an iron-storage protein that rises with inflammation, to albumin, a liver-made protein that falls during inflammation and malnutrition. FAR integrates iron availability with the acute-phase response and hepatic synthesis, linking to energy production, oxygen transport, immunity, vascular integrity, and cardiometabolic risk. Low values usually reflect relatively low ferritin with preserved albumin—most consistent with iron deficiency without significant inflammation. Physiology points to limited hemoglobin and mitochondrial enzyme activity, constraining aerobic energy and cognition. More common in menstruating people, adolescents, and early pregnancy; blood loss and rapid growth also drive low ratios. High values usually reflect an activated acute-phase response—infection, chronic inflammation, tissue injury, cancer, or metabolic stress—where ferritin rises while albumin falls. These indicate systemic stress; true iron overload can also raise FAR when albumin is normal.

FAQs

FAR testing uses standard ferritin and albumin measurements to calculate a ratio that reflects inflammation, iron availability, and protein–nutrition status.

Testing FAR clarifies whether elevated ferritin likely reflects inflammation, whether albumin suggests protein–nutrition strain, and how these forces together may affect energy, recovery, and resilience.

Periodically, and around major changes such as training shifts, diet changes, or recovery from illness. Trends are more informative than one-off values.

Dietary protein and iron intake, acute or chronic inflammation, illness, exercise intensity, hydration status, medications, metabolic health, and liver function.

No special preparation is typically required. For a baseline, test when well hydrated and not immediately after intense exercise or during an acute illness.

Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.

We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.

References

  1. Knovich, M. A., Storey, J. A., Coffman, L. G., Torti, S. V., & Torti, F. M. (2009). Ferritin for the clinician. Blood Reviews, 23(3), 95-104. https://doi.org/10.1016/j.blre.2008.08.001
  2. Sproston, N. R., & Ashworth, J. J. (2018). Role of C-reactive protein at sites of inflammation and infection. Frontiers in Immunology, 9, 754. https://doi.org/10.3389/fimmu.2018.00754
  3. Liu, F., & Liu, Z. (2023). Association between ferritin to albumin ratio and 28-day mortality in patients with sepsis: a retrospective cohort study. European Journal of Medical Research, 28(1), 414. https://doi.org/10.1186/s40001-023-01405-y
  4. Weiss, G., Ganz, T., & Goodnough, L. T. (2019). Anemia of inflammation. Blood, 133(1), 40-50. https://doi.org/10.1182/blood-2018-06-856500
  5. Cappellini, M. D., Musallam, K. M., & Taher, A. T. (2020). Iron deficiency anaemia revisited. Journal of Internal Medicine, 287(2), 153-170. https://doi.org/10.1111/joim.13004

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey